| Literature DB >> 34397728 |
Wisam Sbeit1,2, Amir Mari2,3, Tawfik Khoury1,2.
Abstract
ABSTRACT: Coronavirus disease 2019 (COVID-19) pandemic has impacted our clinical practice. Many gastroenterologists have changed their attitudes toward various gastroenterological clinical settings. The aim of the present study is to explore the gastroenterologist's attitudes in several clinical settings encountered in the clinical practice.An online based survey was completed by 101 of 250 Israeli gastroenterologists (40.5%).Most of the participants were males (76.2%), and most of them were in the age range of 40 to 50 (37.6%). For all questionnaire components, the 2 most common chosen options were "I perform endoscopy with N95 mask, gloves and gown protection in a standard endoscopy room without preendoscopy severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) testing" and "Tend to postpone endoscopy until SARS-CoV-2 test is performed because of fear from being infected, or virus spreading in the endoscopy suite." Notably, 12 (11.9%) gastroenterologists were infected by Coronavirus disease 2019 during their work. Classifying the clinical settings to either elective and non-elective, most gastroenterologists (77.4%) chose the attitude of "I perform endoscopy with N95 mask, gloves and gown protection in a standard endoscopy room without SARS-COV-2 testing" in the nonelective settings as compared to 54.2% for the elective settings, (P < .00001), whereas 32.9% of the responders chose the attitude of "Tend to postpone endoscopy until SARS-COV-2 test is performed because of fear from being infected, or virus spreading in the endoscopy suite" in the elective settings (P < .00001).Gastroenterologists' attitude in various gastroenterological settings was based on the clinical indication. Further studies are needed to assess the long-term consequences of the different attitudes.Entities:
Mesh:
Year: 2021 PMID: 34397728 PMCID: PMC8322517 DOI: 10.1097/MD.0000000000026781
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Baseline characteristics and professional data of the study participants.
| Total no. of gastroenterologist | 101 |
| Sex, N (%) | |
| Male | 77 (76.2) |
| Female | 24 (23.8) |
| Age categories, y, N (%) | |
| <40 | 24 (23.8) |
| 40–50 | 38 (37.6) |
| 51–60 | 30 (29.7) |
| >60 | 9 (8.9) |
| No. of years in gastroenterology practice, N (%) | |
| <10 | 47 (46.5) |
| 11–20 | 29 (28.7) |
| 21–30 | 20 (19.8) |
| >30 | 5 (5) |
| Subfield in gastroenterology, N (%) | |
| Advanced/hepatobiliary | 38 (37.6) |
| Gastro-oncology | 6 (5.9) |
| Motility | 9 (8.9) |
| Hepatology | 15 (14.9) |
| Inflammatory bowel disease | 19 (18.8) |
| Nutrition | 8 (7.9) |
| General | 6 (6) |
| Position, N (%) | |
| Senior | 91 (90.1) |
| resident | 10 (9.9) |
| Medical center resources, N (%) | |
| High | 56 (55.4) |
| Moderate | 39 (38.6) |
| Low | 6 (6) |
Gastroenterologists attitude in various gastrointestinal settings.
| No. (%) | ∗N95, gloves and gown in standard room | †PPE in standard room | ‡Postpone procedure to prevent viral spreading | §Perform electively | ||PPE in dedicated room | ¶Perform MRI |
| Stable UGIB | 71 (70.3) | 6 (5.9) | 24 (23.8) | 0 | 0 | 0 |
| Unstable UGIB | 87 (86.1) | 10 (9.9) | 3 (3) | 0 | 1 (1) | 0 |
| Stable LGIB | 71 (71) | 4 (4) | 25 (25) | 0 | 0 | 0 |
| Unstable LGIB | 81 (81) | 10 (10) | 8 (8) | 0 | 1 (1) | 0 |
| Stable cholangitis | 69 (69.7) | 4 (4) | 25 (25.3) | 0 | 1 (1) | 0 |
| Unstable cholangitis | 81 (82.7) | 12 (12.2) | 4 (4.1) | 0 | 1 (1) | 0 |
| foreign body Ingestion | 82 (81.2) | 10 (9.9) | 9 (8.9) | 0 | 0 | 0 |
| Occult fecal blood test | 54 (53.5) | 4 (4) | 38 (37.6) | 5 (4.9) | 0 | 0 |
| Abdominal pain | 58 (57.4) | 2 (2) | 36 (35.6) | 5 (5) | 0 | 0 |
| Iron deficiency anemia | 55 (54.5) | 2 (2) | 36 (35.6) | 8 (7.9) | 0 | 0 |
| Low-grade dysplasia polyp surveillance | 50 (49.5) | 4 (4) | 35 (34.6) | 12 (11.9) | 0 | 0 |
| High-grade dysplasia polyp surveillance | 58 (57.4) | 3 (3) | 34 (33.7) | 6 (5.9) | 0 | 0 |
| High-risk CRC | 55 (54.5) | 2 (2) | 36 (35.6) | 8 (7.9) | 0 | 0 |
| Average-risk CRC | 45 (45) | 2 (2) | 35 (35) | 17 (17) | 1 (1) | 0 |
| PEG insertion | 55 (55) | 2 (2) | 36 (36) | 7 (7) | 0 | 0 |
| Suspected CBD stones | 44 (44.9) | 3 (3.1) | 27 (27.5) | 3 (3.1) | 1 (1) | 20 (20.4) |
| Pancreatic cysts follow-up | 37 (37.8) | 2 (2) | 25 (25.6) | 12 (12.2) | 0 | 22 (22.4) |
| Esophageal varices secondary prevention | 61 (62.2) | 5 (5.1) | 25 (25.5) | 4 (4.1) | 3 (3.1) | 0 |
| Planned stent exchange | 55 (56.7) | 4 (4.1) | 31 (32) | 7 (7.2) | 0 | |
| Suspected GIT mass by radiology | 62 (62.7) | 2 (2) | 31 (31.3) | 4 (4) | 0 | 0 |
| GIT wall thickening by radiology | 63 (62.3) | 2 (2) | 33 (32.7) | 3 (3) | 0 | 0 |
| Suspected IBD | 60 (60) | 2 (2) | 34 (34) | 4 (4) | 0 | 0 |
Figure 1Demonstrates the rate of gastroenterologists who were infected with SARS-COV-2 and quarantined during their work.
Baseline characteristics and professional data of the study participants infected with SARS-COV-2.
| Total no. | 12 |
| Sex, N (%) | |
| Male | 8 (66.7) |
| Female | 4 (33.3) |
| Age categories, y, N (%) | |
| <40 | 4 (33.3) |
| 40–50 | 3 (25) |
| 51–60 | 4 (33.3) |
| >60 | 1 (8.4) |
| No. of years in gastroenterology practice, N (%) | |
| <10 | 6 (50) |
| 11–20 | 4 (33.3) |
| 21–30 | 2 (16.7) |
| >30 | 0 |
| Subfield in gastroenterology, N (%) | |
| Advanced/hepatobiliary | 4 (33.3) |
| Gastro-oncology | 0 |
| Motility | 1 (8.4) |
| Hepatology | 3 (25) |
| Inflammatory bowel disease | 3 (25) |
| Nutrition | 1 (8.4) |
| General | 0 |
| Position, N (%) | |
| Senior | 11 (91.7) |
| resident | 1 (8.3) |
| Medical center resources, N (%) | |
| High | 6 (50) |
| Moderate | 6 (50) |
| Low | 0 |
Gastroenterologists infected with SARS-COV-2 attitude in various gastrointestinal settings.
| No. (%) | ∗N95, gloves and gown in standard room | †PPE in standard room | ‡Postpone procedure to prevent viral spreading | §Perform electively | ||PPE in dedicated room | ¶Perform MRI |
| Stable UGIB | 11 (91.7) | 0 | 1 (8.3) | 0 | 0 | 0 |
| Unstable UGIB | 12 (100) | 0 | 0 | 0 | 0 | 0 |
| Stable LGIB | 11 (91.7) | 0 | 1 (8.3) | 0 | 0 | 0 |
| Unstable LGIB | 12 (100) | 0 | 0 | 0 | 0 | 0 |
| Stable cholangitis | 11 (91.7) | 0 | 1 (8.3) | 0 | 0 | 0 |
| Unstable cholangitis | 12 (100) | 0 | 0 | 0 | 0 | 0 |
| foreign body Ingestion | 11 (91.7) | 0 | 1 (8.3) | 0 | 0 | 0 |
| Occult fecal blood test | 5 (41.7) | 0 | 7 (58.3) | 0 | 0 | 0 |
| Abdominal pain | 6 (50) | 0 | 6 (50) | 0 | 0 | 0 |
| Iron deficiency anemia | 5 (41.7) | 0 | 6 (50) | 1 (8.3) | 0 | 0 |
| Low grade dysplasia polyp surveillance | 6 (50) | 0 | 5 (41.7) | 1 (8.3) | 0 | 0 |
| High grade dysplasia polyp surveillance | 5 (41.7) | 0 | 7 (58.3) | 0 | 0 | 0 |
| High risk CRC | 5 (41.7) | 0 | 7 (58.3) | 0 | 0 | 0 |
| Average risk CRC | 5 (41.7) | 0 | 6 (50) | 1 (8.3) | 0 | 0 |
| PEG insertion | 5 (41.7) | 0 | 6 (50) | 1 (8.3) | 0 | 0 |
| Suspected CBD stones | 3 (25) | 0 | 4 (33.3) | 0 | 0 | 5 (41.7) |
| Pancreatic cysts follow-up | 3 (25) | 0 | 3 (25) | 0 | 0 | 6 (50) |
| Esophageal varices secondary prevention | 9 (75) | 0 | 3 (25) | 0 | 0 | 0 |
| Planned stent exchange | 7 (58.3) | 0 | 5 (41.7) | 0 | 0 | 0 |
| Suspected GIT mass by radiology | 7 (58.3) | 0 | 5 (41.7) | 0 | 0 | 0 |
| GIT wall thickening by radiology | 7 (58.3) | 0 | 5 (41.7) | 0 | 0 | 0 |
| Suspected IBD | 7 (58.3) | 0 | 5 (41.7) | 0 | 0 | 0 |
Demonstrates the responses details of gastroenterologists infected vs not-infected by COVID-19.
| ∗N95, gloves and gown in standard room | †Postpone procedure to prevent viral spreading | |||
| No. (%) | Infected with SARS-COV-2 | Not infected with SARS-COV-2 | Infected with SARS-COV-2 | Not infected with SARS-COV-2 |
| Total no. | 12 | 89 | 12 | 89 |
| Stable UGIB | 11 (91.7) | 60 (67.4) | 1 (8.3) | 22 (24.7) |
| Unstable UGIB | 12 (100) | 75 (84.3) | 0 | 3 (3.4) |
| Stable LGIB | 11 (91.7) | 60 (67.4) | 1 (8.3) | 23 (25.8) |
| Unstable LGIB | 12 (100) | 69 (77.5) | 0 | 8 (9) |
| Stable cholangitis | 11 (91.7) | 58 (65.2) | 1 (8.3) | 23 (25.8) |
| Unstable cholangitis | 12 (100) | 69 (77.5) | 0 | 4 (4.5) |
| foreign body Ingestion | 11 (91.7) | 71 (79.8) | 1 (8.3) | 8 (9) |
| Occult fecal blood test | 5 (41.7) | 49 (55.1) | 7 (58.3) | 30 (33.7) |
| Abdominal pain | 6 (50) | 52 (58.4) | 6 (50) | 30 (33.7) |
| Iron deficiency anemia | 5 (41.7) | 50 (56.2) | 6 (50) | 30 (33.7) |
| Low-grade dysplasia polyp surveillance | 6 (50) | 44 (49.4) | 5 (41.7) | 30 (33.7) |
| High grade dysplasia polyp surveillance | 5 (41.7) | 53 (59.6) | 7 (58.3) | 27 (30.3) |
| High-risk CRC | 5 (41.7) | 50 (56.2) | 7 (58.3) | 29 (32.6) |
| Average risk CRC | 5 (41.7) | 40 (44.9) | 6 (50) | 29 (32.6) |
| PEG insertion | 5 (41.7) | 50 (56.2) | 6 (50) | 30 (33.7) |
| Suspected CBD stones | 3 (25) | 41 (46.1) | 4 (33.3) | 23 (25.8) |
| Pancreatic cysts follow-up | 3 (25) | 34 (38.2) | 3 (25) | 22 (24.7) |
| Esophageal varices secondary prevention | 9 (75) | 52 (58.4) | 3 (25) | 22 (24.7) |
| Planned stent exchange | 7 (58.3) | 48 (53.9) | 5 (41.7) | 26 (29.2) |
| Suspected GIT mass by radiology | 7 (58.3) | 55 (61.8) | 5 (41.7) | 26 (29.2) |
| GIT wall thickening by radiology | 7 (58.3) | 56 (62.9) | 5 (41.7) | 28 (31.4) |
| Suspected IBD | 7 (58.3) | 53 (59.6) | 5 (41.7) | 29 (32.6) |
Demonstrates the difference in responses among elective and nonelective clinical settings.
| No. (%) | ∗N95, gloves and gown in standard room | †PPE in standard room | ‡Postpone procedure to prevent viral spreading | §Perform electively | ||PPE in dedicated room | ¶Perform MRI |
| Nonelective settings (Total of 700 responses) | 542 (77.4) | 56 (8) | 98 (14) | 0 | 4 (0.57) | 0 |
| Elective settings (Total of 1497 responses) | 812 (54.2) | 41 (2.7) | 492 (32.9) | 104 (6.9) | 5 (0.33) | 42 (2.8) |
| <.00001 | <.00001 | <.00001 | – | .4 | — |